HS-20108

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-20108, covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of HS-20108 in Participants With Advanced Solid Tumors [Phase 1]